OBJECTIVE: To assess the effectiveness of a specific set of vaginal dilators (Amielle Comfort) as a part of vestibulodynia therapy. STUDY DESIGN: Fifteen women referred for vestibulodynia, localized vulvodynia, were advised to use vaginal dilators (Amielle Comfort) accompanied by standardized instructions, after previously receiving 1 or more therapies for the vestibulodynia. RESULTS: The post-treatment Marinoff scale for dyspareunia significantly improved in patients after vaginal dilator treatment compared with baseline values (2.2 +/- 0.4 vs 1.1 +/- 0.9; P < .01), and the Female Sexual Function Index scores were significantly improved compared with the prestudy values (16.3 +/- 5.5 vs 25.3 +/- 7.5; P < .01). CONCLUSION: Among women with previous therapy for vestibulodynia, vaginal dilator use was associated with improvement in symptoms. Vaginal dilators can play an important role in overcoming pelvic floor muscular responses that remain and sometimes increase after pain perception has decreased.
OBJECTIVE: To assess the effectiveness of a specific set of vaginal dilators (Amielle Comfort) as a part of vestibulodynia therapy. STUDY DESIGN: Fifteen women referred for vestibulodynia, localized vulvodynia, were advised to use vaginal dilators (Amielle Comfort) accompanied by standardized instructions, after previously receiving 1 or more therapies for the vestibulodynia. RESULTS: The post-treatment Marinoff scale for dyspareunia significantly improved in patients after vaginal dilator treatment compared with baseline values (2.2 +/- 0.4 vs 1.1 +/- 0.9; P < .01), and the Female Sexual Function Index scores were significantly improved compared with the prestudy values (16.3 +/- 5.5 vs 25.3 +/- 7.5; P < .01). CONCLUSION: Among women with previous therapy for vestibulodynia, vaginal dilator use was associated with improvement in symptoms. Vaginal dilators can play an important role in overcoming pelvic floor muscular responses that remain and sometimes increase after pain perception has decreased.
Authors: Hope K Haefner; Michael E Collins; Gordon D Davis; Libby Edwards; David C Foster; Elizabeth Dee Heaton Hartmann; Raymond H Kaufman; Peter J Lynch; Lynette J Margesson; Micheline Moyal-Barracco; Claudia K Piper; Barbara D Reed; Elizabeth G Stewart; Edward J Wilkinson Journal: J Low Genit Tract Dis Date: 2005-01 Impact factor: 1.925
Authors: Lior Lowenstein; Yoram Vardi; Michael Deutsch; Michael Friedman; Ilan Gruenwald; Michal Granot; Elliot Sprecher; David Yarnitsky Journal: Pain Date: 2004-01 Impact factor: 6.961
Authors: Megan O Schimpf; Heidi S Harvie; Tola B Omotosho; Lee B Epstein; Marjorie Jean-Michel; Cedric K Olivera; Kristin E Rooney; Sunil Balgobin; Okechukwu A Ibeanu; Rajiv B Gala; Rebecca G Rogers Journal: Int Urogynecol J Date: 2009-12-04 Impact factor: 2.894